Nova R Wealth Inc. decreased its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The firm owned 253,725 shares of the company’s stock after selling 27,624 shares during the quarter. BlackRock Health Sciences Trust makes up about 4.0% of Nova R Wealth Inc.’s holdings, making the stock its 8th biggest holding. Nova R Wealth Inc.’s holdings in BlackRock Health Sciences Trust were worth $9,446,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Legacy Wealth Managment LLC ID bought a new position in shares of BlackRock Health Sciences Trust in the second quarter worth about $55,000. Farther Finance Advisors LLC purchased a new stake in BlackRock Health Sciences Trust in the 2nd quarter valued at about $75,000. SOA Wealth Advisors LLC. grew its stake in BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after acquiring an additional 469 shares in the last quarter. Geneos Wealth Management Inc. increased its position in shares of BlackRock Health Sciences Trust by 200.0% during the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after acquiring an additional 3,266 shares during the period. Finally, Comerica Bank increased its position in shares of BlackRock Health Sciences Trust by 7.9% during the first quarter. Comerica Bank now owns 4,807 shares of the company’s stock worth $186,000 after acquiring an additional 353 shares during the period.
BlackRock Health Sciences Trust Stock Down 0.5%
Shares of NYSE BME opened at $41.84 on Friday. BlackRock Health Sciences Trust has a twelve month low of $34.18 and a twelve month high of $42.35. The business has a fifty day simple moving average of $40.52 and a two-hundred day simple moving average of $38.03.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
